← Azimuth Daily
Capturing data…
Capturing data…
FRI, 25 SEPT · 76 ITEMS
"FDA approves Eli Lilly's once-weekly insulin injection for type 2 diabetes" — Reuters (via Google News) · Science & Medicine
The U.S. Food and Drug Administration (FDA) has approved Eli Lilly's new once-weekly injection, branded as (), for adults with type 2 diabetes. This is a significant step forward in diabetes care, as it reduces the injection frequency from daily to weekly, potentially improving patient adherence and quality of life. It is the second once-weekly insulin to reach the market, following Novo Nordisk's Awiqli (insulin icodec), which was approved earlier.
The claim is solid, based on official FDA approval reported by multiple reputable outlets (Reuters, Pharmacy Times, Drug Topics) within hours of the announcement. The primary source is the FDA's regulatory action and Eli Lilly's press release, and the reporting closely reflects those official statements.
This is genuinely new: the FDA approval was announced on September 24, 2026, and all search results are from the past few hours.